| Schedule of Effect of Shares No Longer Anti-Dilutive |
This exclusion only applies to the three months ended June 30, 2025, since the Company recorded income during the three months ended June 30, 2026 and therefore the effect of these shares was no longer anti-dilutive. | | | Three months ended June 30, 2026 | | | Three months ended June 30, 2025 | | | Anti-dilutive securities not included in the calculation of diluted EPS (weighted average): | | | | | | | | Convertible debt | | | 2,524,723 | | | | - | | | Warrants | | | 709,040 | | | | - | | | Convertible series C preferred stock | | | 112,738 | | | | - | | | Stock options | | | 202 | | | | - | | | Common stock subscribed but unissued | | | 44 | | | | - | | | Non-vested RSUs outstanding | | | 2,283,392 | | | | 4,443,516 | | | Total | | | 5,630,139 | | | | 4,443,516 | |
|
| Schedule of Computation of Basic and Diluted Income (Loss) Per Share |
The following table sets forth the computation of basic and diluted income (loss) per share for the three-month periods ending June 30, 2026 and 2025: | | | Three months ended June 30, 2026 | | | Three months ended June 30, 2025 | | | Weighted average # of common shares outstanding, basic | | | 67,688,153 | | | | 50,428,522 | | | Weighted average # of vested RSUs outstanding | | | 6,309,082 | | | | - | | | Weighted average # of common shares outstanding, basic and diluted | | | 73,997,235 | | | | 50,428,522 | | | | | | | | | | | | | Net income (loss) attributable to common stockholders | | $ | 3,795,674 | | | $ | (12,131,954 | ) | | Net income (loss) per share, basic and diluted | | $ | 0.05 | | | $ | (0.24 | ) | | Weighted average # of common shares outstanding, basic | | | 73,997,235 | | | | 50,428,522 | | | Effect of convertible debt | | | 2,524,723 | | | | - | | | Effect of warrants | | | 709,040 | | | | - | | | Effect of convertible series C preferred stock | | | 112,738 | | | | - | | | Effect of stock options | | | 202 | | | | - | | | Effect of common stock subscribed but unissued | | | 44 | | | | - | | | Effect of non-vested RSUs outstanding | | | 2,283,392 | | | | - | | | Weighted-average shares outstanding – diluted | | | 79,627,374 | | | | 50,428,522 | | | Net income (loss) attributable to common stockholders | | $ | 3,975,674 | | | $ | (12,131,954 | ) | | Income (loss) per share, diluted | | $ | 0.06 | | | $ | (0.24 | ) |
|